Related Experiment Video

Updated: Jun 21, 2026

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis (NASH) Resolution
04:14

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis (NASH) Resolution

Published on: April 16, 2019

Metformin plus pentoxifylline versus prescriptive diet in non-alcoholic steatohepatitis (NASH): a randomized

N Sturm, J-P Bronowicki, M Maynard-Muet

    Gastroenterologie Clinique Et Biologique
    |August 4, 2009
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
    10:17

    An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes

    Published on: April 26, 2019

    Related Experiment Videos

    Last Updated: Jun 21, 2026

    Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis (NASH) Resolution
    04:14

    Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis (NASH) Resolution

    Published on: April 16, 2019

    An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
    10:17

    An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes

    Published on: April 26, 2019

    Related Concept Videos

    Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

    Oral Hypoglycemic Agents: Biguanides and Glitazones

    Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...
    Chronic Pancreatitis II: Collaborative Care01:29

    Chronic Pancreatitis II: Collaborative Care

    The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
    Assessment:

    Articles linked to this work by shared authors, journal, and citation graph.

    Maintenance rucaparib after first-line platinum-based chemotherapy in HER2-negative advanced oesophagogastric adenocarcinoma: results from the PLATFORM study.

    ESMO open·2026

    Seizure Risk in Patients With Brain Metastases: Interim Analysis From a Prospective Observational Study. Is it Time to Review Driving Policy?

    Clinical oncology (Royal College of Radiologists (Great Britain))·2026

    [Relevance of the ACT score in severe asthma with obesity: A pilot study].

    Revue des maladies respiratoires·2026

    Management of severe acute alcoholic hepatitis in France: results of a national survey: R1.

    Clinics and research in hepatology and gastroenterology·2026

    Role of Post-operative Thyroglobulin in Predicting Disease-recurrence in Differentiated Thyroid Cancer.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2026

    Chronic anterior sinus atelectasis due to middle meatus retraction.

    European annals of otorhinolaryngology, head and neck diseases·2025

    [Treatment of chronic hepatitis B: adherence and safety].

    Gastroenterologie clinique et biologique·2010

    [Long-term therapy for chronic hepatitis B in HIV co-infected patients].

    Gastroenterologie clinique et biologique·2010

    [Analogs combination therapy in chronic hepatitis B: when and how?].

    Gastroenterologie clinique et biologique·2010

    [HBsAg seroclearance: prognostic value for the response to treatment and the long-term outcome].

    Gastroenterologie clinique et biologique·2010

    [HBsAg quantification: virological significance].

    Gastroenterologie clinique et biologique·2010

    [Influence of treatment on long-term evolution of chronic hepatitis B].

    Gastroenterologie clinique et biologique·2010

    Revisiting gut microbiota-driven ammonia metabolism: from disease burden to physiological adaptation.

    Gut microbes·2026

    Decision-Support Framework for Nutritional Risk in Small Cell Lung Cancer: A Time-Series Model Using Imputation Strategies for Incomplete Clinical Data.

    Thoracic cancer·2026

    Elevated Circulating Fibroblast Growth Factor 21 in Lean Type 2 Diabetes: Evidence of Metabolic Dysregulation in the Absence of Adiposity.

    Kansas journal of medicine·2026

    Engineered Marine Polysaccharide Carriers for Targeted Delivery in Diabetes Management.

    International journal of nanomedicine·2026

    Prevalence and risk factors of malnutrition in elderly patients with diabetes mellitus: a meta-analysis and systematic review.

    Frontiers in nutrition·2026

    The hallmarks of protein and amino acid restriction in aging and longevity.

    Cell press blue·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us